冰上的免疫力:甲基胺对外围免疫力的影响
Emily J Miller1, Habibeh Khoshbouei1
1Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.
Advances in pharmacology (San Diego, Calif.)
|March 11, 2024
概括
甲基胺 (METH) 影响大脑和免疫细胞中的多巴胺转运体 (DAT). 本综述探讨了METH如何影响先天性和适应性免疫,突出了研究缺陷.
科学领域:
- 神经免疫学 神经免疫学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 甲基胺 (METH) 广泛影响中枢神经系统 (CNS) 通过多巴胺载体 (DAT) 的多巴胺传输.
- 新兴研究揭示了中枢神经系统和外周免疫系统之间的双向通信.
- 在外周免疫细胞上的多巴胺载体 (DAT) 表达表明METH可能会在中枢神经系统之外调节免疫力.
研究的目的:
- 审查当前对METH如何影响先天性和适应性免疫的理解.
- 为了确定METH免疫调节效应的知识差距.
- 为指导神经免疫学和METH对免疫的影响的未来研究方向.
主要方法:
- 对METH,多巴胺载体 (DAT),中枢神经系统和外周免疫力研究的文献综述.
- 对将多巴胺信号与免疫细胞功能联系起来的研究分析.
- 确定研究METH对DAT表达免疫细胞的直接影响的研究.
主要成果:
- METH对DAT的调节会影响中枢神经系统的多巴胺传递.
- 周边免疫细胞表达DAT,这表明METH可以直接影响周边免疫力.
- METH可能会启动影响中枢神经系统-外周免疫系统通信的前进布.
结论:
- METH对DAT的影响扩展到外围免疫细胞,影响先天性和适应性免疫.
- 需要进一步的研究来充分阐明METH复杂的神经免疫相互作用.
- 了解这些相互作用对于解决METH更广泛的健康后果至关重要.
相关概念视频
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Phase II Reactions: Methylation Reactions
187
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
187
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Adrenergic Agonists: Mixed-Action Agents
709
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
709


